Latest NEO reports update at 2024-04-30: 2024-Q12023-Q42023-Q1
NeoGenomics logo

NeoGenomics NEO

$ 15.3 3.94%

Country

usaUSA

IPO year

-

Industry

Diagnostics research

Stock Exchange

NASDAQ GLOBALSPB

CEO

Mr. Douglas VanOort

Employees in the company

1 700

Shares

126 M

Market Cap[1]

$ 1.92 B

EBITDA (LTM)

$ -83.2 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.